Dr. Reddy’s Laboratories Limited Q1, Q2, Q3, Q4, FY 2016-17, FY 2015-16 Standalone / Consolidated Results, Revenues, Net Profit, Tax, EPS, Live Chart …

Dr. Reddy’s Laboratories Limited Company Profile :

Dr. Reddy’s Laboratories Limited is an Indian multinational pharmaceutical company.

Dr. Reddy’s manufactures and markets a wide range of pharmaceuticals in India and overseas. The Company operates in three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products.

The company has over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology products.


Dr. Reddy's Laboratories ResultsBSE Code : 500124
NSE Symbol : DRREDDY
ISIN No. : INE089A01023
Industry :Pharmaceuticals
Face Value : Rs.5.00


If you are an investor who has shares of Dr. Reddy’s Laboratories or you are an stock market analyst then i am sure you might for Quarterly Results of Dr. Reddy’s Laboratories.

In this article you will find Q1, Q2, Q3, Q4 and FY 2016-17 Results of Dr. Reddy’s Laboratories. That’s not all, you can compare those results with previous year i.e., FY 2015-16 Results of Dr. Reddy’s Laboratories.

Dr. Reddy’s Laboratories Q1 Results 2016-17 :

Dr. Reddy’s Laboratories will announce its Q1 FY 2016-17 Results on 26th July 2016. We will update the table below once the results are announced.

(Values in Cr.) Q1 Standalone Q1 Consolidated
Revenue  2141.50 3222.50
Other Income  391.80  67.00
Total Income  2533.30  3289.50
Expenditure  -1905.70 -3075.90
Interest  -12.60  -14.80
Depreciation  -172.50  -243.60
PBT  442.50  198.80
Tax  -33.40  -52.60
Net Profit 409.10  146.20
Equity 82.80  82.80
EPS 24.13  9.06

Dr. Reddy’s Laboratories will announce its Q2 FY 2016-17 Results in the month of October 2016.

(Values in Cr.) Q2 Standalone Q2 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Dr. Reddy’s Laboratories will announce its Q3 FY 2016-17 Results in the month of January 2017.

(Values in Cr.) Q3 Standalone Q3 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Dr. Reddy’s Laboratories will announce its Q4 FY 2016-17 Results in the month of April 2017.

(Values in Cr.) Q4 Standalone Q4 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Dr. Reddy’s Laboratories will announce its FY 2016-17 Results in the month of April 2017.

(Values in Cr.) FY 2016-17 Standalone FY 2016-17 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Note : We will update the results table above as and when results are announced. Visit again.

Dr. Reddy’s Laboratories Previous Year’s Results (FY 2015-16) :

(Values in Cr.) Standalone Consolidated
Revenue 10207.70  15697.80
Other Income 244.80  269.30
Total Income 10452.50 15967.10
Expenditure -8159.60  -11777.00
Interest -63.80 -82.40
Depreciation -649.10 -970.50
PBT 1580.00  2,675.10
Tax -225.50  -523.70
Net Profit 1354.50  2,151.40
Equity 85.30 85.30
EPS 79.42 126.00

Note : If you like this information about Dr. Reddy’s Laboratories Quarterly Results, then please share it with all your friends, relatives and other investors on Facebook, Twitter, WhatsApp, Email, etc.